I
nflammatory bowel diseases (IBDs) are chronic inflammatory disorders affecting mainly the gastrointestinal tract that include Crohn's disease (CD), ulcerative colitis (UC), and IBD unclassified type (IBD-U). They can be associated with conditions affecting several other organs resulting in the so-called IBD extraintestinal manifestations (EIMs). EIMs affect approximately 10% to 40% of patients. [1] [2] [3] [4] [5] [6] Ocular manifestations of IBD have been recognized since the early descriptions by Crohn in 1925 7 and are one of the most common types of EIMs, affecting approximately 2% to 6% of adult patients. 6, [8] [9] [10] [11] [12] Most commonly observed ocular disorders include acute anterior uveitis and episcleritis, yet other less frequent manifestations have also been reported, including retinal vasculitis, retrobulbar neuritis, keratopathy, orbital myositis, and granulomatous dacryoadenitis. [13] [14] [15] Ocular EIMs seem to be more frequent in CD than in UC, 16 and they tend to be associated with other EIMs, most often with musculoskeletal and cutaneous manifestations. 17 Rarely, they may also precede the onset of intestinal disease. 18 Data on ophthalmologic manifestations in children with IBD are scarce. The overall prevalence seems to be lower when compared with adults, ranging from 0.7% to 1.8%. [19] [20] [21] [22] Notably, several studies have reported a remarkable prevalence (from 6% to 23%) of asymptomatic uveitis (i.e., subclinical active intraocular inflammation detected by slit-lamp examination only) in pediatric patients with IBD, yet the implications of these observations are unclear. [23] [24] [25] In fact, some authors have suggested performing periodic screening eye examination in children with IBD, 26 but there are no clear recommendations on this. Furthermore, these studies have not been reproduced in recent years, i.e., after the introduction of biologic antitumor necrosis factor alpha agents, which have allowed better control of both gastrointestinal manifestations and EIMs. [27] [28] [29] We sought to evaluate the prevalence of ocular involvement in a cohort of children with IBD at a third-level reference center for pediatric gastroenterology.
MATERIALS AND METHODS
Pediatric patients (age 0-17 yr) affected by IBD seen at the Pediatric Gastroenterology Unit of the Institute for Maternal and Child Health IRCCS "Burlo Garofolo" in Trieste, Italy, were offered ophthalmologic evaluation as part of care for IBD between November 2014 and May 2016. We reviewed the records of all patients who underwent ophthalmologic evaluation during this period. Only 1 ophthalmologic evaluation was available for each patient; timing of evaluation was not predefined according to other variables such as time since IBD diagnosis, disease activity, or ongoing treatments. Institutional review board approval is not required for retrospective studies based on medical records only at our institution.
All patients' clinical files were reviewed and the following data were extracted: diagnosis, intestinal disease location according to the Paris classification, 30 disease duration, previous and current medications, previous and current EIMs, previously recorded ocular disorders, or symptoms. Intestinal disease activity was recorded by means of the Pediatric UC Activity Index and Pediatric CD Activity Index in patients with UC and CD, respectively, whereas in patients with IBD-U, it was evaluated by the Physician Global Assessment. Laboratory tests included erythrocyte sedimentation rate, C-reactive protein, and fecal calprotectin, as required by their routine care according to their attending physician.
All patients underwent ophthalmologic evaluation by the same pediatric ophthalmologist (F.P.) with specific expertise in pediatric inflammatory ocular disorders. Ophthalmologic history was reviewed with patients and their caregivers, focusing on both previous and current ocular signs and symptoms and on previous ophthalmologic diagnoses. Ocular examination included external physical examination and slit-lamp biomicroscopy evaluation of the anterior chamber. The presence of cells and flare in the anterior chamber was recorded according to the Standardization of Uveitis Nomenclature Working Group grading schemes. 31 Fundoscopic evaluation of the posterior segment of the eye was also performed. Visual acuity was not tested. Data are expressed as mean 6 standard error. Confidence intervals are calculated according to Miettinen's mid-P exact test.
RESULTS
A total of 94 children were included, 52 boys (55.3%) and 42 girls (44.7%), with ages ranging from 3 to 17 years (mean 13.4 6 3.7 yr). Forty-six patients (25 boys and 21 girls) had UC, 46 patients (25 boys and 21 girls) had CD, and 2 boys had IBD-U. Median disease duration was 3.6 years (range 0-17 yr). The median follow-up at our center was 3.2 years (range 0-12 yr). Demographic and clinical data are reported in Table 1 . Among patients with CD, 31 (67.4%) were in clinical remission and 15 (32.6%) had active disease (13 mild and 2 moderate). Of those with UC, 35 (76%) were in remission, 11 (24%) had active disease (9 mild and 2 moderate). The 2 patients with IBD-U were both in remission. Nonocular EIMs were present in 11 (24%) of the 46 children with CD, in 10 (21.7%) of the 46 children with UC (3 patients had more than 1 EIM), and in 1 of the 2 children with IBD-U. Nonocular EIMs are reported in Table 2 .
Ophthalmological History
No patients reported ocular symptoms at the moment of evaluation. Previous ocular complaints and previous ophthalmologic diagnoses, as recalled by specific patient/caregiver questioning and by review of clinical files, were present in 24 patients (25.5%) ( Table 3) . Among these, we identified only 1 patient with an ophthalmologic diagnosis definitely known to be associated with IBD (i.e., not merely coincidental). The patient was a 17-year-old boy who had been diagnosed with ileocolonic CD at 10 years of age. At that, he also had bilateral eye redness and discomfort; ophthalmologic evaluation had shown bilateral anterior uveitis for which he had been treated with dexamethasone eye drops for 1 month with good response. Uveitis had not recurred after the first episode and subsequent ophthalmologic evaluations were normal, and he 
Ophthalmologic Evaluation
Seven out of 94 (7.4%) patients had some abnormal ocular findings at ophthalmologic evaluation (Table 4) . Two patients had abnormalities definitely known to be associated with IBD or its treatment. One patient, the same boy who had had symptomatic bilateral uveitis at IBD onset, was found to have mild asymptomatic anterior uveitis in the right eye (cells 0.5+, flare 0), for which no treatment was started. CD was in clinical remission at the time of ophthalmologic evaluation while on therapy with azathioprine. At a subsequent follow-up visit 4 months later, uveitis had resolved. Another patient, who had a long history of corticosteroid treatment for UC was found to have initial posterior subcapsular cataract. Other, likely coincidental, ocular findings are reported in Table 4 .
No patient had signs of ocular complications related to previous, unrecognized intraocular inflammatory conditions. The prevalence of uveitis in our study was 1/94 (1.06%) among all patients with IBD (1/46 in patients with CD, 2.2%). The incidence rate of uveitis was 0.3 per 100 patient-years (95% confidence interval, 0.015-1.47 per 100 patient-years).
DISCUSSION
The prevalence of clinically manifest uveitis in our cohort (1.06%) was in line with other studies on the epidemiology of ocular EIMs in children with IBD. There are few data on ocular EIMs in pediatric patients with IBD; their prevalence, however, seems to be lower than in adult patients, being reported between 0.7% and 1.8% in most reports. [19] [20] [21] [22] Nevertheless, it may also be underestimated, as some cases may be unrecognized and treated as nonspecific eye disorders. Similarly also in our study, we cannot completely exclude that some of our patients may have had previous, unreported or unrecognized episodes of intraocular inflammation. In fact, three patients reported previous episodes of "red eyes (not better specified)" for which no further information was available, thus it is not possibly to comment on this.
The only patient with a diagnosis of uveitis had CD. This may possibly confirm a stronger association of ocular EIMs with CD rather than with UC. 6 Remarkably, the overall incidence rate of clinically manifest uveitis (0.3 per 100 patient-years) in our study is very close to that found by Jose et al 20 in North American children, who reported a cumulative incidence of anterior uveitis of 1.8% in 10 years, which equates to an incidence rate of approximately 0.18 per 100 patient-years.
The second aim of our study was to evaluate the prevalence of asymptomatic uveitis in our population. In fact, 3 previous studies had reported a high prevalence of asymptomatic uveitis in pediatric patients with IBD. This may be an important issue because, if confirmed, it may suggest the need for periodic ophthalmologic screening visits for these patients. Hofley et al 24 found asymptomatic uveitis in 4% of their patients with IBD (6/ 147) detected by screening examination. Daum et al 23 reported the prevalence of asymptomatic uveitis in their pediatric patients with IBD to be as high as 23% (6/26) . In both studies, all patients with asymptomatic uveitis had CD and none had a diagnosis of UC. Finally, Rychwalski et al 25 found asymptomatic uveitis in 4/32 (12.5%) patients; of these, 3 had CD and 1 had UC. Combining the results of these 3 studies, most patients with asymptomatic uveitis were male (13/17 overall), most had CD (16/17), most had colonic or ileocolonic disease (12/13 patients; no data are available for those in the study by Rychwalski et al). No clear association emerged for correlation with gastrointestinal disease activity (6/11 patients for whom data are available had active intestinal disease). Most cases of asymptomatic uveitis were mild and resolved without treatment. Notably, these studies have been performed more than 20 years ago (the most recent being from 1997), and they have not been replicated since; furthermore, they were not confirmed in adult patients. 32 Ophthalmologic evaluation in our patients revealed only 1 patient with mild asymptomatic uveitis, which translates to a prevalence of asymptomatic uveitis of 1.06%, far less than previously reported. Furthermore, it should be noted that the same patient was already known for having had symptomatic bilateral uveitis, therefore it cannot be considered a case of asymptomatic uveitis detected by screening. Notably, this patient was male and had ileocolonic CD similar to patients in previous reports. The lower prevalence of asymptomatic uveitis in our cohort than in previous studies may be due to the fact that the majority of our patients had well-controlled bowel disease, as opposed to the aforementioned studies. In fact, while uveitis is classically considered to be poorly related to intestinal disease activity, some studies actually found a significant correlation of uveitis with disease activity in patients with CD (but not in UC). 4 Furthermore, several therapeutic agents used in our patients, including antitumor necrosis factor agents and methotrexate, are active also on uveal tract inflammation and are commonly used for this indication in children with idiopathic uveitis. Therefore, the lower prevalence of asymptomatic uveitis in our study than in the previous ones may be explained by better disease control. In fact, our data may not reflect the real prevalence of uveitis in the natural history of disease, as systemic treatments for IBD may also treat uveitis; however, it may reflect the current state of association between IBD and uveitis in a real life population of children with IBD. Longer, prospective studies, with multiple ophthalmologic evaluations are needed to better define the association between IBD and ocular involvement in children. Although our study is based on a single ophthalmologic evaluation and cannot therefore provide the same amount of data of a longer study with repeated screening ophthalmological visits, it may be worth noting that we did not find any evidence of intraocular complications from possible previous unrecognized uveitis. In fact, although we cannot exclude that some other patient may have had unrecognized asymptomatic uveitis before the study, the absence of ocular complications related to these hypothetic episodes is reassuring because it suggests that asymptomatic uveitis in pediatric IBD, even if present but poorly recognized, tends to have a favorable course. This is in striking contrast with uveitis associated with other pediatric inflammatory disorders such as juvenile idiopathic arthritis, in which untreated asymptomatic uveitis is classically associated with very rapid and potentially severe ocular complications.
Regarding the occurrence of ocular complication related to IBD treatment in their study, Rychwalski et al 25 found that 5 of 32 patients had posterior subcapsular cataract, a known complication of corticosteroid treatment. In the present study, we found only 1 patient with posterior subcapsular cataract; this patient had actually required long-term corticosteroid treatment in the past. These findings are consistent with the use of corticosteroid-sparing treatments in these patients in recent years. Nevertheless, it also highlights the importance of routine ophthalmologic evaluations in patients receiving corticosteroid treatment, including slit-lamp examination and intraocular pressure measurement. The other ocular findings detected in our patients are not known to be definitely associated with IBD and are therefore likely coincidental.
Currently, there are no clear recommendations on ophthalmologic follow-up in children with IBD. The results of our study may be useful for evaluating this issue. In our opinion, it may be prudent to say that every child with IBD undergoes ophthalmologic evaluation (including slit-lamp examination) at the moment of diagnosis and that a low threshold for ophthalmologic evaluation should be maintained subsequently. Patients and caregivers should be educated to recognize signs and symptoms of ocular disease and clearly informed that there is actually an increased risk of ocular involvement in children with IBD compared with general populations. Our data do not presently seem to support the need for periodic screening ophthalmologic evaluations in asymptomatic children with IBD who do not have a history of previous uveitis.
In conclusion, our study confirms available data on the epidemiology of ocular EIMs in pediatric patients with IBD. We could confirm the existence of asymptomatic uveitis in these children, yet its prevalence in our experience seems lower than previously reported, and it was not found in patients without a history of previous clinically evident uveitis. Finally, no signs of intraocular complications from previous, unrecognized uveitis were detected. Conditions definitely associated with IBD or their treatment are in bold.
